Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 2, 2021
Grant Date -
Oct 26, 2017
app pub date -
Sep 15, 2015
filing date -
Sep 15, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to bispecific antigen binding proteins that are capable of binding to both the human CGRP receptor and the human PAC1 receptor. Pharmaceutical compositions comprising the bispecific antigen binding proteins as well as methods for producing them are also disclosed. Methods of using the bispecific antigen binding proteins to ameliorate or treat conditions associated with the two receptors, such as chronic pain, migraine, and cluster headache, are also described.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully